OC
PGEN icon

Oppenheimer & Co’s Precigen PGEN Stock Holding History

Oppenheimer & Co’s Portfolio PGEN Stock Details PGEN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-12,100
Closed -$26K – 1414
2022
Q3 		$26K Sell
12,100
-2,800
-19% -$5.9K ﹤0.01% 1339
2022
Q2 		$20K Sell
14,900
-5,900
-28% -$8.75K ﹤0.01% 1386
2022
Q1 		$44K Hold
20,800
– – ﹤0.01% 1443
2021
Q4 		$77K Sell
20,800
-1,900
-8% -$8.18K ﹤0.01% 1456
2021
Q3 		$113K Hold
22,700
– – ﹤0.01% 1443
2021
Q2 		$148K Buy
+22,700
New +$159K ﹤0.01% 1453
2017
Q1 		– Sell
-47,766
Closed -$1.15M – 1332
2016
Q4 		$1.15M Sell
47,766
-6,987
-13% -$194K 0.03% 516
2016
Q3 		$1.52M Buy
+54,753
New +$1.45M 0.04% 456
2016
Q2 		– Sell
-8,693
Closed -$292K – 1284
2016
Q1 		$292K Sell
8,693
-100
-1% -$3.15K 0.01% 949
2015
Q4 		$263K Sell
8,793
-279
-3% -$9.4K 0.01% 1006
2015
Q3 		$286K Buy
+9,072
New +$443K 0.01% 1006

Other funds holding PGEN

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
IAM
Iridian Asset Management Westport, Connecticut $247M AUM 20.65% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
MP
MSD Partners New York $82.3M AUM 15.13% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Oppenheimer & Co's PGEN Position: Q4 2022 in Review

Oppenheimer & Co sold out of Precigen (PGEN) in Q4 2022, closing a stake of 12,100 shares — an estimated $26K sold.

Oppenheimer & Co first reported a position in PGEN in Q3 2015 and held it in 11 quarters. The position peaked at $1.52M in Q3 2016. 161 funds tracked by Wall St. Rank hold PGEN as of Q4 2022.

  • Oppenheimer & Co reported no remaining Precigen position as of Q4 2022 after selling out during the quarter.
  • Oppenheimer & Co sold 12,100 Precigen shares in Q4 2022, an estimated $26K.
  • Oppenheimer & Co first reported a position in Precigen in Q3 2015 and held it in 11 quarters.
  • Oppenheimer & Co's Precigen position peaked at $1.52M in Q3 2016.
  • 161 funds tracked by Wall St. Rank held Precigen as of Q4 2022.

Based on Oppenheimer & Co's 13F filing for Q4 2022, filed 8 Feb 2023.